Generalised anxiety disorder.
Gale
Christopher
C
Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand.
Oakley-Browne
Mark
M
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000628:therapy; D001569:Benzodiazepines / Q000627:therapeutic use; D002065:Buspirone / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D002243:Carbolines; D001569:Benzodiazepines; D006919:Hydroxyzine; C062769:abecarnil; D002065:Buspirone